GB2197198A - Analgesic preparations - Google Patents

Analgesic preparations Download PDF

Info

Publication number
GB2197198A
GB2197198A GB08725538A GB8725538A GB2197198A GB 2197198 A GB2197198 A GB 2197198A GB 08725538 A GB08725538 A GB 08725538A GB 8725538 A GB8725538 A GB 8725538A GB 2197198 A GB2197198 A GB 2197198A
Authority
GB
United Kingdom
Prior art keywords
tizanidine
ibuprofen
preparation according
treatment
painful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08725538A
Other languages
English (en)
Other versions
GB8725538D0 (en
Inventor
Peter Lardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8725538D0 publication Critical patent/GB8725538D0/en
Publication of GB2197198A publication Critical patent/GB2197198A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08725538A 1986-11-03 1987-10-30 Analgesic preparations Withdrawn GB2197198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637240 1986-11-03

Publications (2)

Publication Number Publication Date
GB8725538D0 GB8725538D0 (en) 1987-12-02
GB2197198A true GB2197198A (en) 1988-05-18

Family

ID=6312966

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08725538A Withdrawn GB2197198A (en) 1986-11-03 1987-10-30 Analgesic preparations

Country Status (18)

Country Link
JP (1) JPS63132834A (pt)
KR (1) KR890007728A (pt)
AU (1) AU8057587A (pt)
BE (1) BE1000265A3 (pt)
DD (1) DD300508A5 (pt)
DK (1) DK574187A (pt)
FR (1) FR2605884B1 (pt)
GB (1) GB2197198A (pt)
GR (1) GR871678B (pt)
HU (1) HUT47849A (pt)
IL (1) IL84344A0 (pt)
IT (1) IT8748554A0 (pt)
LU (1) LU87033A1 (pt)
NL (1) NL8702523A (pt)
PH (1) PH23276A (pt)
PT (1) PT86061B (pt)
SE (1) SE8704240L (pt)
ZA (1) ZA878257B (pt)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
WO2004043431A1 (en) * 2002-11-12 2004-05-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally
EP1992333A1 (en) 2007-05-08 2008-11-19 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Flurbiprofen and muscle relaxant combinations
WO2013159151A1 (en) * 2012-04-27 2013-10-31 Troy Laboratories Pty Ltd Combination meloxicam and xylazine therapy in animals
EP2977045A1 (en) 2014-07-21 2016-01-27 Sanovel Ilac Sanayi ve Ticaret A.S. Zaltoprofen and muscle relaxant combinations
WO2016046189A1 (en) 2014-09-24 2016-03-31 Sanovel Ilac Sanayi Ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012837A1 (de) * 1979-04-10 1980-10-30 Sandoz Ag Analgetische und myotonolytische praeparate
GB2135884B (en) * 1983-03-09 1986-09-17 Sandoz Ltd Analgesic preparations containing tizanidine and paracetamol
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
WO2004043431A1 (en) * 2002-11-12 2004-05-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally
EP1992333A1 (en) 2007-05-08 2008-11-19 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Flurbiprofen and muscle relaxant combinations
US8778391B2 (en) 2007-05-08 2014-07-15 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbiprofen and muscle relaxant combinations
EP2805711A1 (en) 2007-05-08 2014-11-26 Sanovel Ilac Sanayi ve Ticaret A.S. Flurbiprofen and Muscle Relaxant Combinations
WO2013159151A1 (en) * 2012-04-27 2013-10-31 Troy Laboratories Pty Ltd Combination meloxicam and xylazine therapy in animals
EP2977045A1 (en) 2014-07-21 2016-01-27 Sanovel Ilac Sanayi ve Ticaret A.S. Zaltoprofen and muscle relaxant combinations
WO2016012398A1 (en) 2014-07-21 2016-01-28 Sanovel Ilac Sanayi Ve Ticaret A.S. Zaltoprofen and muscle relaxant combinations
WO2016046189A1 (en) 2014-09-24 2016-03-31 Sanovel Ilac Sanayi Ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Also Published As

Publication number Publication date
FR2605884A1 (fr) 1988-05-06
PT86061A (en) 1987-12-01
KR890007728A (ko) 1989-07-05
HUT47849A (en) 1989-04-28
IL84344A0 (en) 1988-04-29
BE1000265A3 (fr) 1988-09-27
NL8702523A (nl) 1988-06-01
DK574187A (da) 1988-05-04
GB8725538D0 (en) 1987-12-02
FR2605884B1 (fr) 1989-05-05
DK574187D0 (da) 1987-11-02
SE8704240L (sv) 1988-05-04
PT86061B (pt) 1990-11-07
IT8748554A0 (it) 1987-10-30
AU8057587A (en) 1988-05-05
SE8704240D0 (sv) 1987-10-30
LU87033A1 (fr) 1988-05-03
PH23276A (en) 1989-06-23
JPS63132834A (ja) 1988-06-04
GR871678B (en) 1988-03-03
DD300508A5 (de) 1992-06-17
ZA878257B (en) 1989-06-28

Similar Documents

Publication Publication Date Title
Gruenthal et al. Gabapentin for the treatment of spasticity in patients with spinal cord injury
König A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis
US4590213A (en) Anti-anxiety method
JP2004531468A5 (pt)
RU2201272C2 (ru) Применение ингибиторов желудочно-кишечной липазы
Yeh et al. Antihypertensive effect of clonidine: Its use alone and in combination with hydrochlorothiazide and guanethidine in the treatment of hypertension
GB2197198A (en) Analgesic preparations
AU666992B2 (en) Pharmaceutical composition for preventing or treating arteriosclerosis
CA1228817A (en) Analgesic preparations
KR100325793B1 (ko) 불안신경증치료제
EP0190851A1 (en) Improved antiinflammatory composition
JP3982889B2 (ja) イブプロフェン含有医薬製剤
JP2584636B2 (ja) 胃炎治療剤
Brown et al. Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis
GB2135884A (en) Analgesic preparations containing tizanidine and paracetamol
RU2101014C1 (ru) Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
JPH0645548B2 (ja) 高血圧症予防・治療剤
MXPA02012917A (es) Medicamentos que contienen cilansetron para el tratamiento de pacientes de ibs masculinos no estre°idos.
WO2005107744A1 (en) Nerve damage
Adams Diflunisal in the management of sprains
JP2000229853A (ja) 生理痛改善用組成物
Solomon, L. & Abrams Bumadizone calcium in the treatment of rheumatoid arthritis
Hossain et al. Floctafenine (Idarac) in the management of rheumatoid arthritis
EP0005733A1 (en) Pharmaceutical compositions for use in the treatment of diabetic nephropathy and method for preparing them
JPH0343248B2 (pt)

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)